Headlands Technologies LLC Has $195,000 Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Headlands Technologies LLC decreased its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 61.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,203 shares of the company's stock after selling 12,814 shares during the period. Headlands Technologies LLC's holdings in Surgery Partners were worth $195,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Janus Henderson Group PLC lifted its holdings in Surgery Partners by 110.2% during the 4th quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock worth $244,616,000 after purchasing an additional 6,057,477 shares during the last quarter. King Street Capital Management L.P. lifted its holdings in Surgery Partners by 93.1% during the 4th quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock worth $59,276,000 after purchasing an additional 1,350,000 shares during the last quarter. Point72 Asset Management L.P. lifted its holdings in Surgery Partners by 224.7% during the 4th quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock worth $36,975,000 after purchasing an additional 1,208,639 shares during the last quarter. Alpine Associates Management Inc. acquired a new stake in Surgery Partners during the 1st quarter worth approximately $13,539,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Surgery Partners by 18.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after purchasing an additional 563,812 shares during the last quarter.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Barclays dropped their price target on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a report on Tuesday, May 27th. Benchmark reissued a "buy" rating and set a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Finally, Bank of America assumed coverage on Surgery Partners in a research note on Monday, July 28th. They set a "buy" rating and a $28.00 price objective on the stock. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $33.00.

Surgery Partners Price Performance

Surgery Partners stock traded up $0.24 during mid-day trading on Tuesday, reaching $22.98. 1,670,823 shares of the company were exchanged, compared to its average volume of 1,794,988. The company has a fifty day simple moving average of $22.14 and a 200-day simple moving average of $23.00. Surgery Partners, Inc. has a 12 month low of $18.87 and a 12 month high of $33.97. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. The firm has a market cap of $2.95 billion, a PE ratio of -16.07 and a beta of 1.82.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $826.20 million for the quarter, compared to the consensus estimate of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%. The company's revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.21 EPS. As a group, equities research analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.